WO2025068850 - METHOD OF TREATING CANCER
National phase entry is expected:
Publication Number
WO/2025/068850
Publication Date
03.04.2025
International Application No.
PCT/IB2024/059228
International Filing Date
23.09.2024
Title **
[English]
METHOD OF TREATING CANCER
[French]
MÉTHODE DE TRAITEMENT DU CANCER
Applicants **
NOVARTIS AG
Inventors
BROBERG, Per Ernst-Uno
FLECK, Juergen Herbert
FOLITAR, Ilia
GALETIC, Ivana
GERICKE, Germo Hans
KPAMEGAN, Euloge
KOZHUHAROVA, Raya Toteva
MARIANI, Maurizio F.
ELANGUNTHAZATX, Kalidas Menon
SANTORO, Paola Maria
SAWHNEY, Amrita Gill
WEGENER, Antje
Priority Data
63/584,928
25.09.2023
US
63/621,705
17.01.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6051 | |
| EPO | Filing, Examination, Granting | 128752 | |
| Japan | Filing, Examination, Granting | 4971 | |
| South Korea | Filing, Examination, Granting | 8918 | |
| USA | Filing, Examination, Granting | 32190 |
Total:
180,882
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
- octreotate, as first line therapy.[French]
-octréotate, en tant que première thérapie de première intention.